Clinical Trials Logo
  1. Home
  2. Endocarditis
  3. NCT00579761
  4. Details
NCT00579761 Clinical Trial

Retrospective Review of Management of Infective Endocarditis

Endocarditis Clinical Trial

Official title:
A Retrospective Review of the Management of Infective Endocarditis in Patients at Virginia Commonwealth University Medical Center From 1996-2006

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT00579761
Other study ID # HM10420
Secondary ID
Status Withdrawn
Phase N/A
First received December 17, 2007
Last updated December 10, 2015

Study information
Verified date December 2015
Source Virginia Commonwealth University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This is an analysis of the outcomes of patients having undergone surgical intervention for infective endocarditis.

Description:

This study will look at the presentations, epidemiology, risk factors, modalities of diagnosis; and the role of specific investigatory tools with surgical intervention and timimg of intervention in patients who underwent surgical treatment for infective endocarditis. Morbidity and Mortality post surgery and prognosis including long term outcome of our patients will be analyzed. Special attention will be made to those patients with pre-operative neurological deficit.

Recruitment information / eligibility
Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Have undergone surgical treatment for infective endocarditis

Exclusion Criteria:

- Less than 18 years old

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States Virginia Commonweath University MCV Hospital Richmond Virginia

Sponsors (1)
Lead Sponsor Collaborator
Virginia Commonwealth University

Country where clinical trial is conducted

United States, 

See also
  Status Clinical Trial Phase
Recruiting NCT05547607 - Clinical and Diagnostic Features of Endocarditis
Completed NCT00750373 - Early Surgery Versus Conventional Treatment in Infective Endocarditis Phase 4
Recruiting NCT03690076 - Human Cardiac Mitochondria in Acute Endocarditis and Obesity
Terminated NCT01734694 - Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients Phase 4
Terminated NCT00995384 - Cardiac Computed Tomography (CT) Scan Compared to Transesophageal Echocardiogram (TEE) in Endocarditis N/A
Completed NCT04309591 - Cytosorb Therapy in Cardiac Surgery
Recruiting NCT05142891 - Renal Tolerance of Amoxicillin and Cloxacillin Combination
Recruiting NCT05703022 - Early Exercise Training in Patients Following Heart Valve Surgery for Infective Endocarditis. N/A
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT03377465 - Biomarkers, Hemodynamic and Echocardiographic Predictors of Ischemic Strokes and Their Influence on the Course and Prognosis N/A
Recruiting NCT03892174 - Cytokine REmoval in CRitically Ill pAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) N/A
Completed NCT03695861 - Contribution of 18F-FDG PET-CT in the Diagnosis and the Detection of Peripheral Emboli of Infectious Endocarditis on Native Valves N/A
Recruiting NCT02759978 - Individualized Diagnosis of Endocarditis and Its Therapy With a Focus on Infected Prosthetic materiAL
Completed NCT00709358 - Diagnosis of Septicaemia by Detection of Microbial DNA in Blood in Severe Infections Phase 4
Terminated NCT03148756 - Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis Phase 2
Enrolling by invitation NCT05156437 - Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) Phase 4
Recruiting NCT06107309 - Suppressive Antibiotic Therapy for Endocarditis
Completed NCT02251262 - Diagnostic Accuracy of 18FDG-PET-CT for Pacing or Defibrillation Lead Infection N/A
Recruiting NCT03112356 - The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials Phase 4
Completed NCT01375257 - Partial Oral Treatment of Endocarditis Phase 4